Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Mullis

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Biomaterials|May 5, 2023
Functional bioengineered tissue models of neurodegenerative diseasesAdam S Mullis, David L Kaplan
ACS Combinatorial Science|March 4, 2020
High-Throughput Synthesis and Screening of Rapidly Degrading Polyanhydride NanoparticlesAdam S Mullis, Sarah J Jacobson, Balaji Narasimhan
ACS Combinatorial Science|April 5, 2018
Automated High-Throughput Synthesis of Protein-Loaded Polyanhydride Nanoparticle LibrariesJonathan T Goodman, Adam S Mullis, Lucas Dunshee, et al.
Nucleic Acids Research|October 19, 2014
Repurposing endogenous type I CRISPR-Cas systems for programmable gene repressionMichelle L Luo, Adam S Mullis, Ryan T Leenay, et al.
Biomedical Materials (Bristol, England)|January 16, 2018
Ligand-cascading nano-delivery devices to enable multiscale targeting of anti-neurodegenerative therapeuticsAdam S Mullis, Benjamin W Schlichtmann, Balaji Narasimhan, et al.
Frontiers in Antibiotics|January 16, 2025
Nanotherapeutic delivery of antibiotic cocktail enhances intra-macrophage killing of <i>Mycobacterium marinum</i>Andrea M Binnebose, Adam S Mullis, Shannon L Haughney, et al.
Plos Neglected Tropical Diseases|September 8, 2020
Biodistribution of degradable polyanhydride particles in Aedes aegypti tissuesEdmund J Norris, Adam S Mullis, Yashdeep Phanse, et al.
Molecular Pharmaceutics|April 12, 2019
Data Analytics Approach for Rational Design of Nanomedicines with Programmable Drug ReleaseAdam S Mullis, Scott R Broderick, Andrea M Binnebose, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 29, 2022
Data analytics-guided rational design of antimicrobial nanomedicines against opportunistic, resistant pathogensAdam S Mullis, Scott R Broderick, Kruttika S Phadke, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 21, 2018
Nanotherapeutic provides dose sparing and improved antimicrobial activity against Brucella melitensis infectionsPaul Lueth, Shannon L Haughney, Andrea M Binnebose, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Biomaterials|May 5, 2023
Functional bioengineered tissue models of neurodegenerative diseasesAdam S Mullis, David L Kaplan
ACS Combinatorial Science|March 4, 2020
High-Throughput Synthesis and Screening of Rapidly Degrading Polyanhydride NanoparticlesAdam S Mullis, Sarah J Jacobson, Balaji Narasimhan
ACS Combinatorial Science|April 5, 2018
Automated High-Throughput Synthesis of Protein-Loaded Polyanhydride Nanoparticle LibrariesJonathan T Goodman, Adam S Mullis, Lucas Dunshee, et al.
Nucleic Acids Research|October 19, 2014
Repurposing endogenous type I CRISPR-Cas systems for programmable gene repressionMichelle L Luo, Adam S Mullis, Ryan T Leenay, et al.
Biomedical Materials (Bristol, England)|January 16, 2018
Ligand-cascading nano-delivery devices to enable multiscale targeting of anti-neurodegenerative therapeuticsAdam S Mullis, Benjamin W Schlichtmann, Balaji Narasimhan, et al.
Frontiers in Antibiotics|January 16, 2025
Nanotherapeutic delivery of antibiotic cocktail enhances intra-macrophage killing of <i>Mycobacterium marinum</i>Andrea M Binnebose, Adam S Mullis, Shannon L Haughney, et al.
Plos Neglected Tropical Diseases|September 8, 2020
Biodistribution of degradable polyanhydride particles in Aedes aegypti tissuesEdmund J Norris, Adam S Mullis, Yashdeep Phanse, et al.
Molecular Pharmaceutics|April 12, 2019
Data Analytics Approach for Rational Design of Nanomedicines with Programmable Drug ReleaseAdam S Mullis, Scott R Broderick, Andrea M Binnebose, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 29, 2022
Data analytics-guided rational design of antimicrobial nanomedicines against opportunistic, resistant pathogensAdam S Mullis, Scott R Broderick, Kruttika S Phadke, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 21, 2018
Nanotherapeutic provides dose sparing and improved antimicrobial activity against Brucella melitensis infectionsPaul Lueth, Shannon L Haughney, Andrea M Binnebose, et al.
Pageof 2